InvestorsHub Logo
Followers 325
Posts 19225
Boards Moderated 1
Alias Born 02/08/2002

Re: None

Tuesday, 03/18/2014 1:03:18 PM

Tuesday, March 18, 2014 1:03:18 PM

Post# of 23979
GTXI This one is starting to make noise, I have an absolute ton of it and have since before its fall from grace. I have averaged down a few times and now finally our chief ihub local bio expert is pushing it.


It is an “ASCO” play, near the bottom as we head into April. The stock formed its real bottom 1.60-1.80 over months. The stock is close to its technical bottom price. 52wk low is $1.31 (it held that for a few days then started climbing to the 1.45-1.60 area then ratched up there to 1.60-1.80 where it has been range bound for a long time other than a short term spike here or there, and 52wk high is $7.24. GTXI won’t release data at ASCO but the CEO stated it would be in the ASCO time frame.

End of Phase II meeting for Enobosarm in Breast Cancer shortly after in June. The company on March 6th closed a private placement done by their chairman. http://yhoo.it/1gCx7Tk The offering was done at price $1.77. http://yhoo.it/1izmcdS .

Short position is 28.3% of the float so if it moves it could move well. This should move higher as shorts cover, combined w/ the positive catalysts.

Volume will be key 700k -1M+ a day- green is necessary Accumulation line on the Graph, though longer term will be critical, OBV shorter term must point north and trend north, if so this is moving and when the covering occurs it may shoot up. jmho










Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.